Disc Medicine to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Disc Medicine (NASDAQ:IRON), a clinical-stage biopharmaceutical company specializing in treatments for hematologic diseases, has announced its participation in two upcoming investor conferences. The company will present at the Stifel 2024 Healthcare Conference on Tuesday, November 19th at 8:35 a.m. ET, and the Jefferies London Healthcare Conference on Thursday, November 21st at 9:30 a.m. GMT. Live webcasts will be accessible through the company's investor relations website, with archived replays available post-events.

News Market Reaction – IRON

-0.32%

-0.32% Session move

In the trading session that priced this news, IRON declined 0.32%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WATERTOWN, Mass., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that company management will present at two upcoming investor conferences:

• Stifel 2024 Healthcare Conference on Tuesday, November 19^th at 8:35 a.m. ET.

• Jefferies London Healthcare Conference on Thursday, November 21^st at 9:30 a.m. GMT.
  

A live webcast of the presentations will be available through the investor relations section of the Company's website at ir.discmedicine.com and an archived replay will be available after the event.

About Disc Medicine

Disc Medicine (NASDAQ:IRON) is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for patients who suffer from serious hematologic diseases. We are building a portfolio of innovative, potentially first-in-class therapeutic candidates that aim to address a wide spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, specifically heme biosynthesis and iron homeostasis. For more information, please visit www.discmedicine.com.

Media Contact

Peg Rusconi
Deerfield Group
peg.rusconi@deerfieldgroup.com

Investor Relations Contact

Christina Tartaglia
Precision AQ
christina.tartaglia@precisionaq.com

FAQ

When will Disc Medicine (IRON) present at the Stifel 2024 Healthcare Conference?

Disc Medicine will present at the Stifel 2024 Healthcare Conference on Tuesday, November 19th at 8:35 a.m. ET.

What time is Disc Medicine's (IRON) presentation at the Jefferies London Healthcare Conference?

Disc Medicine will present at the Jefferies London Healthcare Conference on Thursday, November 21st at 9:30 a.m. GMT.

How can investors watch Disc Medicine's (IRON) conference presentations?

Investors can watch the live webcasts through Disc Medicine's investor relations website at ir.discmedicine.com, with archived replays available after the events.

Which investor conferences is Disc Medicine (IRON) attending in November 2024?

Disc Medicine is attending the Stifel 2024 Healthcare Conference and the Jefferies London Healthcare Conference in November 2024.